StreetInsider.com News Articles

Form SCHEDULE 13G LISATA THERAPEUTICS, Filed by: Branham Justin Earl

Wed, 26 Aug 2026 13:02:00 -0400

si-local-file:///var/storage/secattach/20260826/26980119.html

Form SCHEDULE 13G LISATA THERAPEUTICS, Filed by: Branham Justin Earl

Wed, 26 Aug 2026 13:02:00 -0400

si-local-file:///var/storage/secattach/20260826/26980119.html

Form 10-Q LISATA THERAPEUTICS, For: Jun 30

Thu, 06 Aug 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260806/26883415.html

Form 10-Q LISATA THERAPEUTICS, For: Jun 30

Thu, 06 Aug 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260806/26883415.html

Lisata sues Kuva Labs after merger collapse, cuts 72% of staff

Tue, 04 Aug 2026 07:03:43 -0400

Lisata Therapeutics, Inc. (Nasdaq: LSTA) has filed suit in the Delaware Court of Chancery against Kuva Labs Inc. and its subsidiary Kuva Acquisition Corp. following the termination of a merger agreement signed March 6, 2026.

The clinical-stage pharmaceutical company is seeking damages for the benefit of its stockholders, including a $2,000,000 termination fee it claims is owed under the Agreement and Plan of Merger, alleging Kuva breached the terms of the deal.

Following the merger's collapse, Lisata has eliminated approximately 72% of its full-time employees, including its Executive Vice President of R&D and Chief Medical Officer position. The company said some separated

Lisata sues Kuva Labs after merger collapse, cuts 72% of staff

Tue, 04 Aug 2026 07:03:43 -0400

Lisata sues Kuva Labs after merger collapse, cuts 72% of staff

Tue, 04 Aug 2026 07:03:43 -0400

Lisata sues Kuva Labs after merger collapse, cuts 72% of staff

Tue, 04 Aug 2026 07:03:43 -0400

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Tue, 04 Aug 2026 07:00:00 -0400

Lisata has filed suit against Kuva Labs Inc. and its subsidiary seeking, among other things, damages for the benefit of its stockholders

Lisata’s Board of Directors and management continues to evaluate strategic alternatives to enhance stockholder value

In order to reduce operating expenses and preserve cash to pursue strategic alternatives, Lisata has implemented a reduction in force of approximately 72% of its full-time employees

LIBERTY CORNER, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Tue, 04 Aug 2026 07:00:00 -0400

Lisata has filed suit against Kuva Labs Inc. and its subsidiary seeking, among other things, damages for the benefit of its stockholders

Lisata’s Board of Directors and management continues to evaluate strategic alternatives to enhance stockholder value

In order to reduce operating expenses and preserve cash to pursue strategic alternatives, Lisata has implemented a reduction in force of approximately 72% of its full-time employees

Form 8-K LISATA THERAPEUTICS, For: Aug 03

Tue, 04 Aug 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260804/26860779.html

Form 8-K LISATA THERAPEUTICS, For: Aug 03

Tue, 04 Aug 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260804/26860779.html

Form SC TO-T/A LISATA THERAPEUTICS, Filed by: Kuva Labs, Inc.

Tue, 28 Jul 2026 16:37:00 -0400

si-local-file:///var/storage/secattach/20260728/26827733.html

Form SC TO-T/A LISATA THERAPEUTICS, Filed by: Kuva Labs, Inc.

Tue, 28 Jul 2026 16:37:00 -0400

si-local-file:///var/storage/secattach/20260728/26827733.html

Brookline Capital Markets Downgrades Lisata Therapeutics, Inc (LSTA) to Hold

Mon, 27 Jul 2026 09:53:46 -0400

Brookline Capital Markets analyst Kemp Dolliver downgraded Lisata Therapeutics, Inc (NASDAQ: LSTA) from Buy to Hold.

For an analyst ratings summary and ratings history on Lisata Therapeutics, Inc click here. For more ratings news on Lisata Therapeutics, Inc click here.

Shares of Lisata Therapeutics, Inc closed at $1.67 yesterday.

Form 8-K LISATA THERAPEUTICS, For: Jul 24

Fri, 24 Jul 2026 12:15:00 -0400

si-local-file:///var/storage/secattach/20260724/26812441.html

Form 8-K LISATA THERAPEUTICS, For: Jul 24

Fri, 24 Jul 2026 12:15:00 -0400

si-local-file:///var/storage/secattach/20260724/26812441.html

Form SC 14D9/A LISATA THERAPEUTICS, Filed by: LISATA THERAPEUTICS, INC.

Tue, 21 Jul 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260721/26791645.html

Form SC 14D9/A LISATA THERAPEUTICS, Filed by: LISATA THERAPEUTICS, INC.

Tue, 21 Jul 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260721/26791645.html

Form 8-K LISATA THERAPEUTICS, For: Jul 16

Fri, 17 Jul 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260717/26781792.html

Form 8-K LISATA THERAPEUTICS, For: Jul 16

Fri, 17 Jul 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260717/26781792.html

Form SC 14D9/A LISATA THERAPEUTICS, Filed by: LISATA THERAPEUTICS, INC.

Fri, 17 Jul 2026 06:57:00 -0400

si-local-file:///var/storage/secattach/20260717/26781732.html

Form SC 14D9/A LISATA THERAPEUTICS, Filed by: LISATA THERAPEUTICS, INC.

Fri, 17 Jul 2026 06:57:00 -0400

si-local-file:///var/storage/secattach/20260717/26781732.html

Form SC TO-T/A LISATA THERAPEUTICS, Filed by: Kuva Labs, Inc.

Fri, 17 Jul 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260717/26781525.html

Form SC TO-T/A LISATA THERAPEUTICS, Filed by: Kuva Labs, Inc.

Fri, 17 Jul 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260717/26781525.html